The in vitro activity of netilmicin was compared with that of gentamicin, tobramycin, amikacin, and kanamycin against 636 strains of bacteria recently isolated from clinical sources. Gentamicin was the most active antibiotic, but netilmicin and tobramycin closely paralleled it. Netilmicin was generally fourto eightfold less active than gentamicin against Serratia and group A streptococci, and was twofold less active against Pseudomonas aeruginosa. When effects of inoculum size and concentration of divalent cations in the media were evaluated, netilmicin was shown to be similar to gentamicin in vitro. Minimum inhibitory concentrations for P. aeruginosa were increased as much as 18-fold when the Mg2+ and Ca2+ concentrations were increased to physiological levels in Mueller-Hinton broth.
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The increasing frequency of nosocomial infections caused by. gram-negative bacilli has become one of the major infectious disease problems of the 1970s (7) . Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Serratia nqw account for well over half of all hospital-acquired infections (5) . The aminoglycosides are among the most useful drugs currently available for treating serious infections due to these genera, but the problems associated with their use, that is, development of resistant strains (10, 14, 15, 20) and potential toxicity (2, 3, 6, 9, 11, 12, 13, 19, 21) , are well known.
Because of its broad spectrum, gentamicin has been particularly useful in the treatment of such infections. One of the most worrisome factors in the use of gentamicin is the narrow margin between an effective dose and a toxic dose. Netilmicin, 0-2,6-diamino-2,3,4,6,-tetra-
, is a new semisynthetic aminoglycoside antibiotic that, based on subacute toxicity studies done in rats and dogs, may have less nephrotoxic and ototoxic potential than gentamicin (17) . The purpose of this study is to compare the in vitro activity of netilmicin with that of gentamicin, tobramycin, amikacin, and kanamycin. Serial twofold dilutions of freshly prepared antibiotics were made in the appropriate broth, and 0.05 ml of each dilution was dropped into the wells of a microtiter plate (Cooke Engineering Co.). With the exception ofS. pneumoniae, which was diluted 10-3, overnight broth cultures of the organisms were diluted 10-5 in the appropriate broth, and 0.05 ml was then added to the diluted antibiotic. The plates were placed on a shaker for 5 min, and then incubated overnight at 35°C in ambient air. The MIC was defined as the lowest concentration of antibiotic in which there was no visible growth. The minimal bactericidal concentration (MBC) was determined by using an adaptation of the Steers replicator (18), which delivered approximately 0.003 ml from each well of the microtiter plates to Mueller-Hinton agar. The strains of group D streptococci and S. pneumoniae were subcultured on Mueller-Hinton agar containing 4% defibrinated sheep erythrocytes. Subcultures of S. pneumoniae were incubated overnight at 35°C in a 5% CO2 atmosphere. All other subcultures were incubated overnight at 35°C in ambient air.
MATERIALS AND METHODS
(ii) Agar dilution method. The strains ofN. gonorrhoeae, N. meningitidis, H. influenzae, group A beta-hemolytic streptococci and alpha-hemolytic streptococci (non-group D) were all tested by the twofold agar dilution method with the Steers inocula replicator (18) . Neisseria and Haemophilus were inoculated onto plates containing GC medium base (Difco) supplemented with 1% hemoglobin (BBL) and 1% IsoVitaleX (BBL). Strains of the non-group D alpha-hemolytic streptococci and the group A beta-hemolytic streptococci were cin. In broth adjusted to physiological levels of Ca2+ and Mg2+, netilmicin remained one dilution less active than gentamicin but showed less activity than amikacin. The geometric mean MIC of netilmicin against P. aeruginosa in unadjusted broth was 0.73 ,ug/ml for gentamicin-susceptible strains and 1.35 ,ug/ml for gentamicin-resistant strains. In Ca2+-and Mg2*-adjusted broth, the netilmicin MIC for gentamicin-susceptible P. aeruginosa was 9.6 ,ug/ml, and for gentamicin-resistant strains it was 23.1 ,ug/ml, an 18-fold increase.
Despite the Kirby-Bauer disk susceptibility reports, only a one-dilution difference in the gentamicin MIC was found between those strains ofP. aeruginosa reported as susceptible and those reported as resistant. The "resistant" group had a geometric mean gentamicin MIC of 0.81 ,ug/ml, as compared to 0.45 ug/ml for the susceptible group when tested in standard Mueller-Hinton broth. In broth adjusted to physiological levels of Ca2+ and Mg2+, geometric mean MICs of gentamicin were 5 ,ug/ml for the susceptible group and 11.8 jig/ml for the resistant group. In view of the lack of strong correlation between the reported disk susceptibility test results and the broth dilution MICs, the effect of inoculum size was also examined. Table 1 demonstrates that inoculum size has a more significant effect when the divalent cation content of the broth is low. This is more marked with susceptible strains than with resistant ones. The significance of increased cation con-ANTIMICROB. AGENT8 CHEMOTHIER. tent of the broth was not as great when tobramycin was tested. In standard Mueller-Hinton broth, tobramycin was approximately twofold more active against P. aeruginosa than gentamicin. In Ca2+-and Mg2+-adjusted broth, tobramycin was four-to sixfold more active. Kanamycin was consistently the least active aminoglycoside.
Gentamicin, netilmicin, and tobramycin continued to be the most active aminoglycosides when tested against staphylococci and group D streptococci, as illustrated in Fig. 4 . When tested in Trypticase soy broth, group D streptococci continued to demonstrate their characteristic resistance to aminoglycosides. A striking medium effect was found, however, when MICs in Trypticase soy broth were compared with those determined in Mueller-Hinton broth supplemented with 2% defibrinated sheep erythrocytes. The MICs were 7-to 22-fold higher when measured in Trypticase soy broth. Figure 5 illustrates the results of testing S. pneumoniae, alpha-hemolytic streptococci (non-group D), group A beta-hemolytic streptococci, N. gonorrhoeae, N. meningitidis, and H. influenzae. Once again, gentamicin, netilmicin, and tobramycin were consistently more active than amikacin and kanamycin. DISCUSSION The results of this study show that, with few exceptions, the in vitro activity of netilmicin closely parallels that of gentamicin. The major (4, 8) , the Ca2+ and the Mg2+ concentration of the medium was shown to have an important effect on the MIC of netilmicin when P. aeruginosa was tested. Our data also demonstrate an increased importance of inoculum size when broth low in Mg2+ and Ca2+ is used. This is particularly true of susceptible strains.
Another significant effect is found when media supplemented with sheep blood are used to test aminoglycoside activity against enterococci. This has previously been reported to enhance the activity of gentamicin against enterococci (16). Our data confirm this and extend it to other aminoglycosides.
